MedDataX Logo

Evaluation of Hemodynamics and Amount of Blood Flowing Through the Kidneys During Liver Transplant by Measuring Some Physiological Substances in Blood and Urines

NCT ID: NCT01650116

Last Updated: 2014-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to verify any existing relationship between urinary parameters (such as excretion of sodium, chlorine, urinary partial CO2 pressure \[PuCO2\]) and general volemic indicators (such as PiCCO, ScvO2, O2 delivery) during liver transplant.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypovolemia During Liver Transplantation Renal Hypoperfusion During Liver Transplantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* surgery for liver transplantation
* age 18-75
* ASA class I-III

Exclusion Criteria

* age above 75 or under 18
* ASA class IV
* pre-existing renal failure
* pregnant patients
* patients unable to give written consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda Ospedaliera di Padova

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Paolo Feltracco

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carlo Ori, Prof. M.D.

Role: STUDY_CHAIR

Università degli Studi di Padova - Azienda Ospedaliera di Padova

Paolo Feltracco, M.D.

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliera di Padova

Andrea Bortolato, M.D.

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliera di Padova

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azienda Ospedaliera di Padova

Padua, Padova, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paolo Feltracco, M.D.

Role: CONTACT

[email protected]
+393493410225

Andrea Bortolato, M.D.

Role: CONTACT

[email protected]
+393316169933

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Role: primary

+390498218285

Role: backup

+390498218286

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2661P

Identifier Type: -

Identifier Source: org_study_id